Sanofi-Synthelabo selects Twilio Segment for Customer Data Platform

In 2022, Sanofi-Synthelabo, a United States based Healthcare organization with 16000 employees and revenues of $843M selected Twilio Segment for Customer Data Platform while displacing Legacy, and integrating with the existing systems being used.

Customer Vendor Old Product New Product Category Market Users VAR/SI When Live
Sanofi-Synthelabo Twilio Legacy Twilio Segment Customer Data Platform CRM n/a n/a 2022 2022
Discover the latest software purchases and digital transformation initiatives being undertaken by Sanofi-Synthelabo and its business and technology executives by accessing the entire Sanofi-Synthelabo and its business and technology executives by becoming a Premium Subscriber. On a continuous basis, our research team identifies and updates the on-prem and cloud applications that are being used by Sanofi-Synthelabo employees from publicly available data (Press Releases, Customer References, Case Studies, Success Stories, Testimonials, RFP, RFI, etc.) as well as proprietary sources, and incorporate them into the customer profile.

Don't miss the entire: Sanofi-Synthelabo Technographics profile